Skip to main content
ATRC
NASDAQ Industrial Applications And Services

AtriCure 10-Q: Q3 Revenue $154.5M, First Nine-Month Profit, $260M SentreHEART Suit Detailed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$64.895
Mkt Cap
$3.301B
52W Low
$25.36
52W High
$65
52W Position info
156% above low
Off High info
at 52W high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ATRC has more than doubled off its 52-week low of $25.36.

Summary

AtriCure's Q3 10-Q confirms $154.5M revenue (+15.0%) and $4.1M net income, with nine-month profit of $13.1M versus a year-ago loss, $187.0M of cash, and a SentreHEART lawsuit seeking up to $260.0M that carries no booked liability.


Key Events · Earnings and Guidance · ATRC

  • Q3 Revenue Up 15.0% to $154.5M

    Worldwide revenue rose 15.0% to $154,450 thousand from $134,269 thousand, with U.S. revenue up 17.1% to $128,049 thousand on pain management (+34.6%) and open ablation (+20.8%).

  • Nine-Month Swing to $13.1M Profit

    Nine-month net income was $13,127 thousand versus a $13,204 thousand loss in 2025; Q3 gross margin improved to 77.3% from 75.5%, while R&D rose 40.3% to $32,116 thousand including a $4,500 thousand acquired IPR&D milestone.

  • $260M SentreHEART Suit, No Liability Booked

    Former SentreHEART securityholders seek damages of up to $260,000 thousand plus interest; no liability is recognized because any potential loss is not currently probable or reasonably estimable.

  • Cash $187.0M Against $61.0M Drawn

    Cash and equivalents were $187,031 thousand with $61,000 thousand drawn on the $125,000 thousand ABL facility and $62,750 thousand unused capacity; a $23,287 thousand finance lease liability was recorded as the Mason, Ohio expansion was completed.


Analysis · ATRC · Industrial Applications And Services

The 10-Q backs up the prior day's headline Q3 release with the full picture: revenue of $154.5M (+15.0%) and net income of $4.1M, lifting the nine-month result to $13.1M of profit versus a $13.2M loss a year earlier. Gross margin improved to 77.3% from 75.5%, but R&D jumped 40.3% to $32.1M, including a $4.5M acquired IPR&D milestone payment, so operating leverage is thinner than the top line suggests. The balance sheet is comfortable — $187.0M of cash against $61.0M drawn on the ABL facility — but the filing also puts a hard number on the SentreHEART dispute: former securityholders seek up to $260.0M plus interest, and no liability is booked because management says a loss is not probable or reasonably estimable. That claim is the single largest swing factor in the equity story.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ATRC was trading at $64.90 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.3B. The 52-week trading range was $25.36 to $65.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ATRC - Latest Insights

ATRC
Nov 03, 2026, 4:01 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $60.41
Real-time Price: $55.24 info
Change: -$5.17 (-9%) info
Market Cap: $2.828B info
ATRC
Nov 03, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $60.35
Real-time Price: $55.24 info
Change: -$5.11 (-8%) info
Market Cap: $2.828B info
ATRC
Jul 27, 2026, 1:07 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $37.31
Real-time Price: $55.24 info
Change: +$17.93 (+48%) info
Market Cap: $2.828B info
ATRC
Jul 23, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $34.71
Real-time Price: $55.24 info
Change: +$20.53 (+59%) info
Market Cap: $2.828B info
ATRC
May 19, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $28.80
Real-time Price: $55.24 info
Change: +$26.44 (+92%) info
Market Cap: $2.828B info